Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Benzonapthyridine Composition and Uses, 4342 [2014-01436]

Download as PDF 4342 Federal Register / Vol. 79, No. 17 / Monday, January 27, 2014 / Notices DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Dynamic Exoskeletal Orthosis Department of the Army, DoD. Notice. AGENCY: ACTION: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/773,776, entitled ‘‘Dynamic Exoskeletal Orthosis,’’ filed on February 22, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to an ankle foot orthosis or brace, in particular to a dynamic exoskeletal orthosis. SUMMARY: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01437 Filed 1–24–14; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Benzonapthyridine Composition and Uses Department of the Army, DoD. Notice. AGENCY: ACTION: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/640,832, entitled ‘‘Benzonapthyridine Composition and Uses,’’ filed on April 13, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:16 Jan 24, 2014 Jkt 232001 Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to compositions comprising benzonapthridine small molecule immune potentiators (SMIPs) that are capable of stimulating or Modulating an immune response in a subject that has had pre- or postexposure to a pathogen such as hemorrhagic fever virus. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014–01436 Filed 1–24–14; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Defense Acquisition Regulations System [Docket No. DARS–2013–0045] Submission for OMB Review; Comment Request ACTION: Notice. The Defense Acquisition Regulations System has submitted to OMB for clearance the following proposal for collection of information under the provisions of the Paperwork Reduction Act (44 U.S.C. chapter 35). DATES: Consideration will be given to all comments received by February 26, 2014. Title, Associated Form, and OMB Number: Defense Federal Acquisition Regulation Supplement (DFARS) part 244, Subcontracting Policies and Procedures; OMB Control Number 0704–0253. Type of Request: Extension. Number of Respondents: 90 Responses per Respondent: 1 Annual Responses: 90 Average Burden per Response: Approximately 16 hours Annual Burden Hours: 1,440 Needs and Uses: Administrative contracting officers use this information in making decisions to grant, withhold, or withdraw purchasing system approval at the conclusion of a purchasing system review. Withdrawal of purchasing system approval would necessitate Government consent to individual subcontracts. PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 Affected Public: Businesses or other for-profit and not-for profit institutions. Frequency: On Occasion. OMB Desk Officer: Ms. Jasmeet Seehra. Written comments and recommendations on the proposed information collection should be sent to Ms. Seehra at the Office of Management and Budget, Desk Officer for DoD, Room 10236, New Executive Office Building, Washington, DC 20503. You may also submit comments, identified by docket number and title, by the following method: Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. Instructions: All submissions received must include the agency name, docket number, and title for the Federal Register document. The general policy for comments and other public submissions from members of the public is to make these submissions available for public viewing on the Internet at https://www.regulations.gov as they are received without change, including any personal identifiers or contact information provided. To confirm receipt of your comment(s), please check https://www.regulations.gov approximately two to three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). DoD Clearance Officer: Ms. Patricia Toppings. Written requests for copies of the information collection proposal should be sent to Ms. Toppings at WHS/ESD/ Information Management Division, 4800 Mark Center Drive, 2nd Floor, East Tower, Suite 02G09, Alexandria, VA 22350–3100. Manuel Quinones, Editor, Defense Acquisition Regulations System. [FR Doc. 2014–01554 Filed 1–24–14; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army, Corps of Engineers Notice of Availability for the Final Supplemental Environmental Impact Statement for the Proposed San Acacia to Bosque del Apache Project, Socorro County, New Mexico Department of the Army, U.S. Army Corps of Engineers, DoD. ACTION: Notice of availability—Final SEIS. AGENCY: In accordance with the National Environmental Policy Act of SUMMARY: E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 79, Number 17 (Monday, January 27, 2014)]
[Notices]
[Page 4342]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01436]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning 
Benzonapthyridine Composition and Uses

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 13/640,832, 
entitled ``Benzonapthyridine Composition and Uses,'' filed on April 13, 
2011. The United States Government, as represented by the Secretary of 
the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to compositions 
comprising benzonapthridine small molecule immune potentiators (SMIPs) 
that are capable of stimulating or Modulating an immune response in a 
subject that has had pre- or post- exposure to a pathogen such as 
hemorrhagic fever virus.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01436 Filed 1-24-14; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.